News: Chambers-Grundy Center for Transformative Neuroscience
Entities sign Memorandum of Understanding to cultivate best-in-class clinical research services for Alzheimer’s and other neurodegenerative diseases.
First-of-its-kind database, supported by Alzheimer's Drug Discovery Foundation, will provide greater access to key data on Alzheimer’s to researchers around the world.
Alzheimer’s treatment studies offer hope as 51³Ô¹ÏºÚÁÏ expert predicts new potential drugs, biomarkers will yield critical insight for future development.
Amanda Osse is the first recipient of the award named in honor of Nathan Lindsay, who passed away after a 15-year battle with Alzheimer's disease.
A roundup of prominent news stories highlighting university pride, research, and community collaboration.
Annual review of current Alzheimer’s clinical trials reveals trends in design, therapies, outcomes, and funding surrounding work to develop new treatments.
A collection of news stories highlighting research wins, expert insights, and academic achievement.
51³Ô¹ÏºÚÁÏ expert Dr. Jeffrey Cummings explains how a new lab expands 51³Ô¹ÏºÚÁÏ's neuroscience research capabilities.
51³Ô¹ÏºÚÁÏ researchers made international headlines this year with their discoveries. Here's a roundup of some of our top stories of 2021.
The longtime 51³Ô¹ÏºÚÁÏ researcher on youthful curiosity, the brain, and sports.
The Chambers-Grundy Center for Transformative Neuroscience will advance research and the science of treatment for Alzheimer’s and other neurological disorders.
51³Ô¹ÏºÚÁÏ’s new Department of Brain Health leads interdisciplinary effort to answer tough questions about traumatic brain injury.